CATHEPSIN CYSTEINE PROTEASE INHIBITORS

This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis. La présente i...

Full description

Saved in:
Bibliographic Details
Main Authors XU, SHIMIN, PAONE, DANIEL, V, FU, JIANMIN, STACHEL, SHAWN, GINNETTI, ANTHONY, LI, JING, LIM, JOHN
Format Patent
LanguageEnglish
French
Published 16.04.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis. La présente invention concerne une nouvelle classe de composés qui sont des inhibiteurs de protéases à cystéine, comprenant entre autres, des inhibiteurs de cathepsines K, L, S et B. Ces composés sont utiles pour le traitement de maladies, telles que l'ostéoporose, dans lesquelles l'inhibition de la résorption osseuse est indiquée.
Bibliography:Application Number: WO2014US58934